Find therapies in clinical trials near you – page 47

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Phase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa